期刊文献+

Tuning the Stability of the Polyplex Nanovesicles of Oligonucleotides via a Zinc(Ⅱ)-Coordinative Strategy

原文传递
导出
摘要 Oligonucleotide therapeutics have great potential to target the currently undruggable genes and to generate entirely new therapeutic paradigms in multiple types of disease,thus having attracted much attention in recent years.However,their applications are greatly hindered by a lack of safe and efficient oligonucleotide-delivery vectors.Polyplex nanovesicles formed from oligonucleotides and the cationic block have shown exceptional features for the delivery of therapeutic oligonucleotides and other biopharmaceuticals.Nevertheless,these polyplex nanovesicles are deeply fraught with difficulty in tolerating physiological ionic strength.Inspired by the high binding ability between the dipicolylamine(DPA)/zinc(Ⅱ)complex and the phosphodiester moieties of oligonucleotides,herein,we designed a coordinative cationic block to solve the intrinsic stability dilemma.Moreover,we found the stability of the resulted polyplex nanovesicles could be easily tuned by the content of coordinated zinc ions.In vitro cellular studies implied that the prepared zinc(Ⅱ)-coordinative polyplex nanovesicles preferred to retain in the lysosomes upon internalization,making them ideal delivery candidates for the lysosome-targeting oligonucleotide therapeutics.
出处 《Chinese Journal of Polymer Science》 SCIE EI CAS CSCD 2022年第9期1034-1042,共9页 高分子科学(英文版)
基金 financially supported by the National Key Research and Development Program of China (No.2021YFA1201200) the National Natural Science Foundation of China (Nos. 51833008, 52173141 and 82102192) Zhejiang Provincial Key Research and Development Program (No.2020C01123) China Postdoctoral Science Foundation (No.2019M662059)
  • 相关文献

参考文献1

二级参考文献40

  • 1Kay, M.A., Nat. Rev. Genet., 2011, 12(5):316.
  • 2Shim, M.S. and Kwon, Y.J., Adv. Drug Deliv. Rev., 2012, 64(11):1046.
  • 3Giacca, M. and Zacchigna, S., J. Control. Release, 2012, 161(2):377.
  • 4Yin, H., Kanasty, R.L., Eltoukhy, A.A., Vegas, A.J., Dorkin, J.R. and Anderson, D.G., Nat. Rev. Genet., 2014, 15(8):541.
  • 5Choi, Y.S., Lee, M.Y., David, A.E. and Park, Y.S., Mol. Cell Toxicol., 2014, 10(1):1.
  • 6Malamas, A.S., Gujrati, M., Kummitha, C.M., Xu, R.Z. and Lu, Z.R., J. Control. Release, 2013, 171(3):296.
  • 7Ozpolat, B., Sood, A.K. and Lopez-Berestein, G., Adv. Drug Deliv. Rev., 2014, 66:110.
  • 8Ambardekar, V.V., Wakaskar, R.R., Sharma, B., Bowman, J., Vayaboury, W., Singh, R.K. and Vetro, J.A., Biomaterials, 2013, 34(20):4839.
  • 9Zhou, J.H., Ke, F.Y., Xia, Y.Q., Sun, J.B., Xu, N., Li, Z.C. and Liang, D.H., Polymer, 2013, 54(10):2521.
  • 10Qu, W., Chen, S., Ren, S., Jiang, X.J., Zhuo, R.X. and Zhang, X.Z., Chinese J. Polym. Sci., 2013, 31(5):713.

共引文献2

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部